Order Article Reprints

Ciancio A, Ribaldone DG, Spertino M, Risso A, Ferrarotti D, Caviglia GP, Carucci P, Gaia S, Rolle E, Sacco M, et al. Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study. Biomedicines. 2023; 11(1):166. https://doi.org/10.3390/biomedicines11010166

Ciancio, Alessia, Davide Giuseppe Ribaldone, Matteo Spertino, Alessandra Risso, Debora Ferrarotti, Gian Paolo Caviglia, Patrizia Carucci, Silvia Gaia, Emanuela Rolle, Marco Sacco, and et al. 2023. "Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study" Biomedicines 11, no. 1: 166. https://doi.org/10.3390/biomedicines11010166

Ciancio, A., Ribaldone, D. G., Spertino, M., Risso, A., Ferrarotti, D., Caviglia, G. P., Carucci, P., Gaia, S., Rolle, E., Sacco, M., & Saracco, G. M. (2023). Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study. Biomedicines, 11(1), 166. https://doi.org/10.3390/biomedicines11010166